ePrints@IIScePrints@IISc Home | About | Browse | Latest Additions | Advanced Search | Contact | Help

Essential role of PI3-kinase pathway in p53-mediated transcription: Implications in cancer chemotherapy

Suvasini, R and Somasundaram, K (2010) Essential role of PI3-kinase pathway in p53-mediated transcription: Implications in cancer chemotherapy. In: Oncogene, 29 (25). pp. 3605-3618.

[img] PDF
P53.pdf - Published Version
Restricted to Registered users only

Download (949Kb) | Request a copy
Official URL: http://www.nature.com/onc/journal/v29/n25/abs/onc2...

Abstract

The PI3-kinase pathway is the target of inactivation in achieving better cancer chemotherapy. Here, we report that p53-mediated transcription is inhibited by pharmacological inhibitors and a dominant-negative mutant of PI3-kinase, and this inhibition was relieved by a constitutively active mutant of PI3-kinase. Akt/PKB and mTOR, the downstream effectors of PI3-kinase, were also found to be essential. LY294002 (PI3-kinase inhibitor) pre-treatment altered the post-translational modifications and the sub-cellular localization of p53. Although LY294002 increased the chemosensitivity of cells to low concentrations of adriamycin (adriamycin-low), it protected the cells from cytotoxicity induced by high concentrations of adriamycin (adriamycin-high) in a p53-dependent manner. Further, we found that LY294002 completely abolished the activation of p53 target genes (particularly pro-apoptotic) under adriamycin-high conditions, whereas it only marginally repressed the p53 target genes under adriamycin-low conditions; in fact, it further activated the transcription of NOXA, HRK, APAF1 and CASP5 genes. Thus, the differential effect of PI3-kinase on p53 functions seems to be responsible for the differential regulation of DNA damage-induced cytotoxicity and cell death by PI3-kinase. Our finding becomes relevant in the light of ongoing combination chemotherapy trials with the PI3-kinase pathway inhibitors and underscores the importance of p53 status in the careful formulation of combination chemotherapies. Oncogene (2010) 29, 3605-3618; doi: 10.1038/onc.2010.123; published online 26 April 2010

Item Type: Journal Article
Additional Information: Copyright of this article belongs to Nature Publishing Group.
Keywords: p53;PI3-kinase;chemosensitivity;chemotherapy
Department/Centre: Division of Biological Sciences > Microbiology & Cell Biology
Date Deposited: 13 Jul 2010 06:15
Last Modified: 19 Sep 2010 06:11
URI: http://eprints.iisc.ernet.in/id/eprint/29190

Actions (login required)

View Item View Item